OMT & Intractable Singultus

This study plans to use the effects osteopathic manipulative medicine (OMM) techniques to aid in treatment of patients with symptoms of, somatic dysfunction related to, and/or a diagnosis of Intractable Singultus. The aim of our study is to document any changes in associated symptoms of Intractable Singultus before and after osteopathic manipulative treatment (OMT).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hiccup Pathological Conditions, Signs and Symptoms Signs and Symptoms Signs and Symptoms, Digestive

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MSU OMM Clinic

East Lansing, Michigan, 48823, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Over 18 years old
Living with daily episodes of hiccups that have lasted longer than 1 month

Exclusion criteria

Any contraindications to OMT based on screening questionnaire or during treatment.

Treatment and study plan

Osteopathic Manipulative Therapy

Procedure

1 session of OMT

Other names: ONMM, OMM

Primary outcomes

Number of Hiccups

Time frame: Days 1-7 before OMT (baseline), and Days 1-7 following OMT

Sponsors and collaborators

Lead sponsor

Michigan State University

Other

Registry information

Official study title

Intractable Singultus Pilot Study

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Aug 29, 2025
Registry last updated: Aug 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed